Singapore: Sky News has reported that GlaxoSmithKline (GSK) is in talks with Japanese firm Suntory to sell its drugs Luc...
Singapore: Boston Strategics Corp (BSC), a clinical-stage drug research and development (R&D) company has signed an ...
Singapore: Dehaier Medical has obtained a medical equipment procurement agreement valued at approximately $320,580 (RMB...
Singapore: Japan-headquartered Otsuka Pharmaceutical and Turkish firm Abdi Ibrahim have established a joint venture, Abd...
Singapore: Frost & Sullivan partner Ms Reenita Das during her keynote presentation at the 12th International BIOtech...
Singapore: AstraZeneca has received approval from the Japanese Ministry of Health, Labour and Welfare for a supplemental...
Singapore: Japan-headquartered Eisai's UK manufacturing subsidiary Eisai Manufacturing, situated within the company's Eu...
Singapore: Snoasis Medical has signed a distribution agreement with Hausten Healthcare, whereby Hausten Healthcare will ...
Singapore: Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a US subsidiary of To...
Singapore: Furiex Pharmaceuticals and Menarini Group have signed an agreement giving Menarini rights to commercialize Pr...
Singapore: Human Metabolome Technologies, a Japanese company that deals in capillary electrophoresis mass spectrometry (...
Singapore: US-based Response Genetics, a company focused on the development and sale of molecular diagnostic tests that ...
Singapore: Eisai suspended sales of its epilepsy drug Fycompa (perampanel) in Germany due to unfavorable conditions set ...
Singapore: Daiichi Sankyo Company and ArQule announced the top-line results of a randomized phase II signal generation ...
Singapore: Takeda Pharmaceutical International completed the construction of its pharmaceutical manufacturing facility a...
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...
Singapore: A*STAR's Immunology Network (SIgN), Singapore, and Immunology Frontier Research Center (IFReC), Osaka Univers...
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...
Singapore: Takeda Pharmaceutical, which has completed the acquisition of URL Pharma, will immediately assume responsibil...
Singapore: Shionogi, US, received US FDA approval for Osphena (ospemifene) tablets for the treatment of moderate to se...
Singapore: Toshiba Medical Systems, part of Japan-based Toshiba Corporation, has entered into a partnership with Manches...
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...
Singapore: Takeda today announced the launch of a new expert report on COPD on the occasion of the 2012 European Respira...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
The Asian business strategy of multinational pharmaceutical companies in terms of resource reallocation and investment w...
Singapore: Western Europe, the US and Japan will continue to account for almost 60 percent of the total market, accordin...
Singapore: This year, the Tenth Takamine Memorial Daiichi Sankyo Prize will be awarded to Dr Takeshi Iwatsubo, professor...
Singapore: Swiss company Covagen has entered into a strategic research collaboration and license agreement with Japanese...
Singapore: Daiichi Sankyo has announced data from the PRASFIT-ACS study, a double-blind randomized phase III trial compa...
Singapore: US-based Precision Spine has signed a long-term exclusive distribution agreement with Mizuho Ikakogyo. Mizuho...
Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko...
Singapore: Retina Institute Japan (RIJ), RIKEN, Japan, and Dainippon Sumitomo Pharma (DSP) have signed an agreement acco...
Singapore: Lantheus Medical Imaging, a global leader in developing, manufacturing and distributing innovative diagnosti...
Singapore: A former employee of the Japanese drug maker Novartis, was arrested with allegations of data manipulation. So...
Eisai's UK subsidiary, Eisai Europe, has received a positive opinion from the European Medicines Agency's Committee for ...
Singapore: Takeda Pharmaceutical and H. Lundbeck A/S have submitted a new drug application (NDA) to the US Food and Drug...
Singapore: Boston Scientific's Japanese subsidiary has join hands with Fukuda Denshi to market and sell the former's Sp...
Singapore: Daiichi Sankyo's affiliate, the Japan Research Foundation for Clinical Pharmacology, has awarded its 5th Japa...
Singapore: FibroGen and Japanese company Astellas Pharma have initiated the first clinical study in the phase III clinic...
Singapore: Even as the industry is gearing up for BIOtech Japan 2014 that starts on May 14 at Tokyo Big Sight this year,...
Singapore: US-based Spiracur and Century Medical (CMI), Japan, have announced multiple system sales of the SNaP Wound Ca...
Singapore: Eisai signed an agreement with US-based Epizyme and Roche Molecular Systems to collaborate on the development...
Singapore: Dr Reddy's Laboratories Limited is planning to make a fresh foray into the Japanese market. "We are explorin...
Singapore: A team of scientists from Japan have created a functioning human liver from stem cells, raising hopes of manu...
Singapore: Nobelpharma and Eisai launched Gliadel 7.7 mg Implant (carmustine), an antineoplastic agent, in Japan on Janu...
Singapore: Takeda Pharmaceutical has submitted a new drug application (NDA) to the Ministry of Health, Labor and Welfare...
Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...
Singapore: Sysmex Corporation and Siemens Healthcare Diagnostics have announced the signing of a five-year global supply...
Singapore: Sucampo (an affiliate of Sucampo Pharmaceuticals), R-Tech Ueno, Takeda Pharmaceutical, and certain affiliate...
Japan's Chugai Pharmaceutical, which pursues cutting-edge biopharmaceutical, antibody, and molecular targeted research t...
Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...
Singapore: Japan's health ministry has lodged a criminal complaint against the local wing of the leading Swiss drug make...
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...
Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...
Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...
Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...
Singapore: Mylan Specialty, a subsidiary of Mylan, and Pfizer entered into a license agreement, under which Pfizer will ...
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...
Singapore: Stroke, the destruction of brain tissue from blockage or rupture of blood vessels, is one of the leading caus...
Singapore: Japanese pharmaceutical company Eisai has said that it will soon begin therapeutic testing of a drug that it ...
Singapore: Eisai has expressed strong disappointment with Institute for Quality and Efficiency in Health Care (IQWiG), G...
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...
Singapore: Sosei has successfully completed a Japanese phase I trial for SO-1105 for the treatment of oropharyngeal cand...
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...
Singapore: Takeda Pharmaceutical and Pfizer Japan have concluded an agreement that, as of December 31, 2012, Takeda will...
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...
Singapore: Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry's production facili...
Singapore: Kyowa Hakko Kirin has agreed to return development and marketing rights of Busulfex, for use as a part of con...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Leading biopharmaceutical company Aegerion Pharmaceuticals that is dedicated to the development and commercia...
Not long ago, it was one of India's iconic companies. Ranbaxy, which is now a subsidiary of Japanese giant Daiichi Sanky...
Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of...
Singapore: Japanese pharmaceutical major Takeda has been ordered by a US Federal court to pay $6 billion in punitive dam...
Singapore: Cellectricon has expanded its sales and service network into Asia through a distribution agreement for its D...
Singapore: Japanese drug major Mitsubishi Tanabe Pharma has announced that one of its subsidiaries, Tianjin Tanabe Seiya...
Singapore: Scientists at Kyoto University, Japan, have discovered the 'reset button' in the brain, which could be used t...
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...
Singapore: St Jude Medical, a global medical device company, launched Ilumien Optis System, a next-generation technology...
Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...
Singapore: Takeda Pharmaceutical has recieved Japan's approval for the New Drug Application (NDA) of Zacras tablets, a f...
Singapore: Japan-based Otsuka Pharmaceutical filed an additional indication for ABILIFY (aripiprazole), as Japan's first...
NASDAQ-listed Sucampo Pharmaceuticals Inc. has launched an all-cash tender offer in Japan by Sucampo's Japanese subsidia...
Singapore: Australian drug company Agenix received a key patent covering the manufacturing process of its ThromboView im...
Singapore: The fifth QVA149 (indacaterol maleate / glycopyrronium bromide) phase III study of Novartis, SPARK, met its p...
Singapore: Biotech company ArQule and Japan-based Daiichi Sankyo have achieved positive results from a randomized, place...
Singapore: Tokyo-headquartered Eisai has signed a global agreement with Brazil's Fundação Oswaldo Cruz for collabo...
Singapore: Qualyst Transporter Solutions entered an alliance with GenoMembrane, Kanagawa, Japan, to make available its ...
Singapore: Pieris received the first financial milestone in its discovery and development collaboration with Daiichi Sa...
Singapore: Zoll Medical, a manufacturer of medical devices and related software solutions, has received Shonin approval ...
Singapore: SBI Pharmaceuticals, headquartered in Japan, has concluded a basic agreement to begin clinical research on di...
Singapore: Thailand's Nanotec signed a collaborative Letter of Intent (LoI) with the Nanosystem Research Institute (NRI)...
Singapore: Takeda Oncology and the Worldwide Innovative Network (WIN) in personalized cancer medicine consortium have fo...
Singapore: An investigator-sponsored clinical study in Japan using Cytori's Celution System for treatment of cryptoglan...
Singapore: Oxford Immunotec, a medical diagnostic company developing tests in the fields of infectious and immunologica...
Singapore: Medtronic launched the Resolute Integrity Coronary Stent System in Japan, which is the world's second largest...
A rapidly aging population has burdened the healthcare system both in terms of funding and facilities and is of great co...
Singapore: Clearbridge BioMedics has won the 2012 Asian Entrepreneurship Awards, which was held from May 9-11, 2012, in ...
Singapore: India-based Elder Pharmaceuticals is said to be up for sale, according to a report published in the Economic ...
